 in the fields of Iron Chelation and Wound Healing. Iron Chelation development has focused primarily in conditions of Iron Overload, such as thalassemia. Development in the field of Wound Healing has focused on the treatment of hard to heal wounds, such as those found in diabetic patients, where a proprietary product in final stages of development is based on human fibroblasts that generate new skin. The Apotex Group of companies plans to spend a total of $1.3 billion over the next 10 years on research and development.
Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.